Skip to content
Recall Observatory FDA recall evidence

Device product

Autoimmune EIA Anti-Tissue Transglutaminase (tTG) IgA Test; Material Number 425-2260; Lot number 18200A - Product Usage: The assay is an aid in the diagnosis of celiac disease (gluten-sensitive enteropathy) and should be used in conjunction with other serological tests and clinical findings.

Z-1800-2020

April 03, 2019

Class II

Product summary

Firm
Bio-Rad Labs
Event
Event 85074
Status
Completed
Classification
Class II
Quantity
376 units
Official record key
device-enforcement:Z-1800-2020

Official wording

Reason: An elevated lot-to-lot bias was observed for Autoimmune EIA Anti-Tissue Transglutaminase (tTG) IgA when compared to a previous lot of product. The observed elevated bias between these two lots is largely due to samples with higher levels of antibodies. With the cut-off for the assay being 15 U/mL, the clinical classifications for most samples would remain unchanged.

Code information: Catalog Number 425-2260; Lot Number 18200A: UDI 00847817018336.

Distribution pattern: US Nationwide distribution including the states of AZ, NY, LA, FL, CA, TX, IA, MS, UT, and IL.

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    An elevated lot-to-lot bias was observed for Autoimmune EIA Anti-Tissue Transglutaminase (tTG) IgA when compared to a previous lot of product. The observed elevated bias between these two lots is largely due to samples with higher levels of antibodies. With the cut-off for the assay being 15 U/mL, the clinical classifications for most samples would remain unchanged.